What is Uabaco?
Established in 2012, Uabaco operates as a critical provider of drug testing services, addressing the multifaceted challenges of substance abuse in professional environments. By facilitating comprehensive drug-free workplace programs, the company mitigates the significant financial and human costs associated with workplace impairment. Their service model is designed to protect both employers and employees, reducing insurance liabilities and ensuring compliance with state workers' compensation regulations. Through routine testing and rigorous screening protocols, Uabaco serves as a vital partner for organizations seeking to minimize operational risks and foster a safer, more productive workforce.
How much funding has Uabaco raised?
Uabaco has raised a total of $122K across 1 funding round:
Debt
$122K
Debt (2021): $122K with participation from PPP
Key Investors in Uabaco
PPP
Public-Private Partnership
What's next for Uabaco?
With the infusion of this late-stage capital, Uabaco is poised to accelerate its growth trajectory and expand its footprint in the drug-testing market. The strategic allocation of these funds will likely focus on enhancing technological infrastructure for testing accuracy and scaling administrative capacity to meet the increasing demand from state agencies. As the company matures, the focus will shift toward long-term sustainability and the integration of advanced diagnostic tools to maintain its competitive edge in the risk mitigation industry. This financing round provides the necessary runway to solidify Uabaco's role as a leader in workplace safety compliance.
See full Uabaco company page
